Drug Testing Locations - Pittston, PA

Drug Testing in Pittston, PA

Pittston, Pennsylvania Statistics

In Pittston, Luzerne County, opioid overdose deaths saw a notable increase of 15% from 2019 to 2020.

Luzerne County reported 85 emergency room visits related to substance abuse in 2020, a part of Pittston's rising trend.

Pittston reported a 20% rise in arrests related to possession of controlled substances in 2020.

In 2020, Luzerne County had a drug-related death rate of 45 per 100,000 people, affecting communities like Pittston.

Naloxone was administered 70 times in Pittston in 2020 by first responders as part of overdose reversals in Luzerne County.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Pittston, PA & Drug Testing Policies

In Pittston, PA, many employers have implemented drug-free workplace policies to ensure safety and productivity. This has involved pre-employment and random drug testing, in line with guidelines from the U.S. Department of Labor. These policies reflect a commitment to tackling substance abuse issues.

Local businesses, in collaboration with the Pennsylvania Department of Health, aim to promote healthy work environments. This includes offering support services for employees needing assistance with addiction, ensuring a supportive approach to maintaining workplace safety.

Government Efforts with Drug Problems in Pittston, PA

In Pittston, PA, government efforts to combat drug abuse are ongoing. Local initiatives supported by Luzerne County and the Pennsylvania Department of Health focus on education and prevention programs. These efforts are part of a coordinated strategy involving law enforcement and healthcare providers.

The Luzerne County Government works closely with community health organizations to provide resources aimed at reducing substance abuse. Federal grants help fund initiatives that target high-risk groups, while public awareness campaigns aim to educate citizens about the dangers and resources available.

Local Drug Busts & News in Pittston, PA

In recent months, drug busts in Pittston, PA have highlighted a notable rise in local law enforcement activities. These operations have targeted numerous suspects allegedly involved in the distribution of illegal substances. Increased community awareness and vigilance have played key roles in aiding these efforts. The success of these operations hinges on the collaboration between the police department and local residents committed to improving neighborhood safety.

One significant drug-related event in Pittston involved the discovery of a clandestine methamphetamine lab in a residential area. Authorities successfully dismantled the operation, raising concerns about similar hidden activities. The incident prompted calls for greater public education on identifying signs of illegal drug production. This case underscored the ongoing battle against drug contamination in neighborhood environments.

In response to recent drug trends, Pittston law enforcement has initiated proactive community outreach programs. These aim to inform residents about preventing substance abuse and recognizing early warning signs. Partnerships with local schools and organizations seek to equip young individuals with knowledge to resist drug-related pressures. Such initiatives are vital to fostering a safer and healthier community environment.

Ongoing investigations into the distribution of opioids in Pittston have led to a series of targeted raids. These efforts reflect a broader strategy to tackle the complex challenge of addiction, which has affected many families in the area. By targeting the supply chain, law enforcement officials hope to curb the availability of these drugs and inspire more addicts to seek help. Community support for these measures remains crucial.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Pittston, PA. Trusted by employers nationwide for accurate results and exceptional service.

Pennsylvania DOT/Non DOT Physicals

Pennsylvania Vision Tests

Pennsylvania Audiograms

Pennsylvania Respirator Fit Tests

Pennsylvania Lift Tests

Pennsylvania Background Checks

Clinical Testing Services

TB Testing in PA

Diabetes Testing in PA

Infectious Disease Testing in PA

Sickle Cell Anemia Testing in PA

Women/Men's Health Testing in PA

Resources & Citations

Community Advocates for Recovery & Service Alliance

Pennsylvania Department of Drug and Alcohol Programs

PA Department of Health Substance Use Disorder Resources

Luzerne County Drug & Alcohol Program

Hazleton Integration Project Coalition

A Safer PA Luzerne County

Catholic Charities Drug & Alcohol Program

Wyoming Valley Alcohol and Drug Services

Geisinger Health Addiction and Recovery

Northeast PA Consumer and Family Satisfaction Team

Drug Testing Near Pittston, PA

Plains, PA

Old Forge, PA

Moosic, PA

Duryea, PA

Avoca, PA

Laflin, PA

Inkerman, PA

Dupont, PA

Exeter, PA

Yatesville, PA

Hughestown, PA

West Pittston, PA

Frequently Asked Questions

Customer Reviews